Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,270 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

NCT01015625

Conditions
Breast Diseases, Breast Neoplasms, Circulating Tumor Cells, +10 more
Locations
  • Hospital Guessing Guessing, Burgenland, Austria
  • Hospital Oberpullendorf Oberpullendorf, Burgenland, Austria
  • Ordination Dr. Wette Saint Veit A. D. Glan, Carinthia, Austria
  • Gynaegological Medical University Graz Graz, Styria, Austria
View all 14 locations
View Trial Details
Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

NCT01294202

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
Locations
  • Arizona Cancer Center at UMC North Tucson, Arizona, United States
  • Robert H. Lurie Cancer Center of Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

NCT00042003

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Scripps Clinic Escondido, California, United States
  • USC/Norris Cancer Center Los Angeles, California, United States
  • Metro-Minnesota CCOP Saint Louis Park, Minnesota, United States
View Trial Details
Completed

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

NCT04799249

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • Banner M.D. Anderson Cancer Center Gilbert, Arizona, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center - Oncology Research Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists - North (SCRI) St. Petersburg, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 71 locations
View Trial Details
Completed

Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

NCT02848443

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie Vienna, Austria
  • CHU de la Timone Hépato-Gastro-Entérologie - Oncology Digestive Marseille, France
  • Hôpital Saint-Antoine Service d'Oncologie Médicale Paris, France
  • La Pitié Salpêtrière Centre Investigation clinique Paris Est Paris, France
View all 24 locations
View Trial Details
Completed

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

NCT03274882

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Russian Cancer Research Center n.a. NN Blokhin (RCRC), Clinical Pharmacology and Chemotherapy department Moscow, Russia
  • Saint Petersburg Clinical Scientific-Practical Center of Special Medical Care (Oncology Center) Saint Petersburg, Russia
View Trial Details

Related conditions